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Abstract: 
There is a strong link between alcohol use and mental health, yet research often fails to 
provide a comprehensive understanding of the complex interaction between the two 
aspects. In relation to treatment, alcohol and mental health services often work in a 
disjointed manner; likewise, policies and guidelines for the two sectors are generally 
developed in isolation from one another. The result of this silo mentality is that the needs 
of individuals with comorbid alcohol and mental health disorders, commonly referred to 
as “Dual Diagnosis”, are often unmet, leading to serious harmful consequences for the 
affected individuals, their families and society as a whole. This generates further stigma 
and isolation for an already vulnerable and high-risk population. The present Chapter 
provides an overview of the epidemiology, and the main etiological theories of co-
occurring Alcohol Use Disorders (AUD) and Mental Health Disorders (MHD). It is 
hoped that this chapter can inform treatment and policies for this population. 
 
Key Words:  
Dual Diagnosis, co-occurring disorders, comorbidity, alcohol dependence, mental health 
disorders, alcohol, mental health, depression, anxiety 
 
[The prevalence of co-occurring Alcohol Use and Mental Health 
Disorders] 
There is a strong linkage between alcohol use and mental health, with a wide range of 
mental health disorders being more prevalent in people who drink problematically. 
However, determining the prevalence of comorbid Alcohol Use Disorders (AUD) and 
Mental Health Disorders (MHD) is challenging because of the wide variation in the 
definitions, measurements, and instruments used to assess whether individuals met 
diagnostic criteria for AUD and any specific mental disorder (Boden & Fergusson, 2011; 
Anker & Kushner, 2019).   
 
Mood disorders and Anxiety are particularly common in people with AUD (Kushner et 
al., 2012). The prevalence of depression in people seeking treatment for AUD ranges 
from 50 to 70% (Conner et al., 2009). A meta-analysis of 16 cross-sectional and 
longitudinal studies investigating the link between AUD and Major Depression (MD), 
confirmed that the presence of either condition doubles the risks of the second disorder, 
even after controlling for variations of measures of AUD and MD (Boden & Ferguson, 
2011). Subjective measures of depression symptoms in the general population support the 
clinical findings. A survey based on 5828 respondents to the Health Survey for England 
found that the risk of alcohol dependence (determined by the amount of alcohol 
consumed) as well as the experience of alcohol dependence are significantly associated 
with higher levels of self-rated depression (Churchill & Farrell, 2017).  
 
Research into the intersection between anxiety disorders (AD) and AUD found that up to 
50% of individuals receiving treatment for problematic alcohol use also met diagnostic 
criteria for one or more AD (Chunk, Dennis & Funk, 2008; Kushner et al., 2005). 
Similarly, a synthesis of the major epidemiological studies showed that the risk for 
meeting diagnostic criteria for alcohol dependence more than doubled among individuals 
with an AD compared to those with no AD (Kushner et al., 2008). Individuals with social 
anxiety (SA) seem particularly vulnerable to develop AUD (Buckner, Heimberg, Ecker 
and Vinci, 2013). In the National Epidemiologic Survey on Alcohol and Related 
Conditions (NESARC) in USA, 48% of individuals with a lifetime diagnosis of Social 
Anxiety Disorder (SAD) also met criteria for a lifetime diagnosis of an AUD (Grant et 
al., 2005). People with an AUD and lifetime history of SAD generally experience more 
severe alcohol dependence and report more major depressive episodes, less peer social 
support, and lower occupational status than patients without SAD (Buckner et al., 2013). 
Research on the co-existence of AUD and Obsessive-Compulsive Disorders (OCD) is 
relatively scarce in comparison to other subtypes. However, the development of the 
Obsessive–Compulsive Drinking Scale (Anton et al., 1996) signifies the existence of an 
overlap between OCD and AUD. Also, occurrence of obsessive–compulsive symptoms 
has been commonly reported among alcohol dependent patients (Lima et al., 2005). A 
cross-sectional study by Gentil et al., (2008) on 630 OCD patients from seven Brazilian 
university services, compared patients with and without AUD comorbidity. Out of the 
overall sample, 7.5% presented AUD comorbidity. Although the prevalence is lower than 
in other subtypes of AD, comorbidity showed clinical features that deserve special 
attention from mental health professionals, such as increased risk for suicidality, higher 
comorbidity with generalized anxiety and somatization disorders, and compulsive sexual 
behaviour.  
 
An issue in estimating and interpreting the prevalence of comorbid AUD and AD is that 
various subtypes (i.e., social phobia disorder, panic disorder, and generalized anxiety 
disorder) are often present at the same time in the same individual (Kushner et al., 2012). 
Another question is whether subtypes of anxiety disorders have a unique association with 
AUD, or whether each subtype individually contribute a similar increase in the overall 
risk for AUD. Modeling analysis on the NESARC database (N 43,093) was used to 
explore the relationship between risk for alcohol misuse and the shared versus unique 
components of several anxiety and depressive disorders. This analysis showed a strong 
positive relationship between risk for DSM-IV alcohol dependence and the shared 
components of the anxiety and depression diagnoses. However, the analysis also showed 
no relationship between risk for alcohol dependence and the unique components of those 
diagnoses. These findings are consistent with the idea that all anxiety and mood disorders 
contribute to general “negative emotionality”, which, in turn, correlates with the risk for 
alcohol dependence (Kushner et al., 2012). These results support the development of a 
novel integrated “transdiagnostic” therapeutic protocol that focus on common processes 
underlying multiple disorders, for mood and anxiety disorders (Vujanovic et al., 2016). 
 
Post-traumatic stress disorder (PTSD) is also highly associated with alcohol dependence 
(Suh & Ressler, 2018). Particularly vulnerable groups are individuals who have been 
victim of childhood trauma (Brady & Back, 2012) and women affected by domestic 
violence (Kaysen et al, 2007). In addition, women have been found to be more likely to 
have experienced sexual abuse than men in both AUD and MHD clinical and community 
samples (Drapalski, Bennett & Bellack, 2011; Gearon, Nidecker, et al., 2003). Veterans 
are also particularly vulnerable to this comorbidity.  In a nationally representative sample 
of Veterans in US, one of every five Veterans with AUD also screened positive for PTSD 
(Norman et al., 2018). The prevalence is even higher among Veterans seeking care, with 
up to two-thirds of those with AUD also having a diagnosis of PTSD (Seal et al., 2011). 
A high rate of AUD was also found in UK Veterans. For example, a recent UK study by 
Murphy & Turgoose (2019) investigated alcohol misuse and mental health in 403 
treatment-seeking veterans, in comparison to the Armed Forces and the general 
population. They found that although both military samples reported significantly higher 
levels of AUD than the general population, treatment-seeking veterans were significantly 
more likely to report alcohol dependence and alcohol related harm than the two 
comparison groups.  
 
Alcohol is also the most common substance of abuse amongst people with Bipolar 
Disorders, in a meta-analysis of 78 studies of comorbid bipolar disorder and substance 
use disorder, it was found that alcohol use was at 42%, followed by cannabis (20%), 
illicit drugs (17%), cocaine and amphetamine (11%) (Hunt et al., 2016). With regard to 
psychosis, the comorbidity of schizophrenia and AUDs is particularly problematic, as it is 
associated with depression, suicidality, medication nonadherence, chronic physical 
problems, homelessness, aggression, violence, incarceration, and high rates of 
hospitalization (e.g. Hunt et al., 2018). Individuals with schizophrenia spectrum disorders 
have three times the risk of heavy alcohol use relative to the general population (Hartz et 
al., 2014). One meta-analysis of individuals with schizophrenia found a lifetime 
prevalence of AUD of 24.3% and one American study reported that 36.4% of 404 
participants had experienced AUD before their first episode of psychosis. A rarer but 
clinically significant psychotic disorder is alcohol-induced psychotic disorder (AIPD), 
which can occur with acute intoxication, alcohol withdrawal, as well as in patients with 
chronic alcohol use disorder (Jordaan & Emsley, 2013). A review of 21 studies found 
0.4% lifetime prevalence of this disorder in the general population and 4.0% in patients 
with alcohol dependence (Engelhard, Touquet, Tansens and De Fruyt, 2015). Although 
relatively rare, AIPD is a serious condition and is associated with high comorbidity with 
other psychiatric disorders, high re-hospitalization, mortality rates and suicidal behaviour 
(Jordaan & Emsley, 2013). 
 
Alcohol Use Disorders also co-occur at high prevalence with borderline personality 
disorder (BPD) and antisocial personality disorders (ASPD) (Helle, Watts, Trull, and 
Sher, 2019). In a recent review (Trull et al., 2018), of those individuals who met 
diagnostic criteria for BPD, 46% to 49% also met diagnostic criteria for current AUD, 
and 59% for lifetime AUD. Among the general population or clinical samples of 
individuals with a current diagnosis of AUD or alcohol dependence, the prevalence of a 
BPD diagnosis was approximately 12% to 17%. In the same population, ASPD diagnoses 
were slightly more prevalent than BPD diagnoses, ranging from 19% to 22%. However, 
the prevalence of AUD among those diagnosed with ASPD was as high as 68%.  
 
The overlap between Attention Deficit Hyperactive Disorder (ADHD) and substance use 
disorders in general have been long documented (Magon & Müller, 2012). Data on adult 
ADHD comorbidity among individuals with AUD are limited, few studies have indicated 
that adult ADHD is comparatively low among individuals with AUD compared to those 
who use other substances (van de Glind, et al., 2013). Vice versa, the incidence of AUD 
in adults with ADHD has been found to be 33–44% (Rasmussen and Gilberg, 2000). 
While, in a German study of 91 adults with alcohol dependence, 20.9% (WURS-k) or 
23.1% (DSM-IV diagnostic criteria) of the patients showed evidence of retrospective 
ADHD in childhood (Ohlmeier et al., 2008).  
 
Finally, increased attention has recently been given to alcohol-related dementia in the 
elderly population. For example, a UK cohort study of people with a mean age of 56 
found that drinking above 32 UK units of alcohol per week was associated with greater 
global impairment in cognitive function, as well as in memory and executive function 10 
years later (Sabia et al., 2014), these data suggest that alcohol-related dementia represents 
an under-recognised mental disorder with both clinical and public mental health 
implications (Rao, 2014). 
 
In conclusion, there is abundant evidence that the co-occurrence of AUD and MHD is 
highly prevalent and is associated with increased vulnerability, high level of risk to self 
and others, greater psychological and physical impairment and poor prognosis. Thus, 
failing to meet the needs of this population leads to serious consequences for the 
individual and society as a whole, it is therefore paramount that the health and social care 
sectors treat comorbidity as the norm, rather than the exception.  
 
 [Etiological theories: what comes first?]  
There are three main models that explain the etiology of comorbid mental health 
disorders (MHD) and substance use disorders (SUD): 1. The secondary substance use 
models, which suggests that MHD cause SUD; 2. The secondary mental health disorders 
model, which implies that SUD cause MHD; 3. the common risk factor model, which  
suggests that there might be shared neurological and psychosocial vulnerabilities that 
increase the risk of both MHD and SUD. This section will define each model in the 
context of alcohol use disorders (AUD).  
 
(1) The secondary substance use model  
If MHD leads to AUD, by definition, a temporal association should be observed with the 
former preceding the latter. However, research on the order of onset produced 
inconclusive results. One limitation of this line of evidence is that the temporal sequence 
of the disorders does not necessarily imply causality (Anker and Kushner, 2019). In 
addition, it is difficult to establish the exact start of either MHDs or AUD because both 
disorders develop gradually, hence data on order of onset are not very helpful to 
determine causality, especially in regard to schizophrenia or bipolar disorders (Mueser et 
al.,1998). However, research on anxiety disorders (AD) has produced some supportive 
evidence of this direction of causality. For example, Kushner, Sher and Beitman (1990) 
have shown that the onset of AD preceded alcohol misuse in up to three-quarters of 
individuals who had both conditions, subsequent studies demonstrated that this is true 
especially for those who had social anxiety disorders SAD (Buckner, et al. 2013). Grant 
et al. (2005) also found that the AD persisted following a period of abstinence from 
alcohol, indicating that it was an independent diagnosis. There are three explanatory 
models for the observed causal link: the “self-medication hypothesis” (Khantzian, 2013; 
Quitkin, Rifkin, Kaplan, & Klein, 1972), “tension reduction” (Conger, 1956) and 
“stressresponse dampening” (Sher & Levenson, 1982). These three models are based on 
the concept that people with AD attempt to relieve negative consequences of these 
conditions by drinking alcohol to cope with their symptoms, the “negative reinforcement” 
(an unpleasant state is successfully taken away in response to drinking) eventually leads 
to the later onset of AUD (Smith & Randall, 2019). Many studies investigating 
motivations for using alcohol, support this hypothesis (see Smith & Randall, 2012; 
Anker, & Kushner, 2019 for a review on the topic), however, most laboratory studies did 
not find a direct impact of alcohol on the physiological response among those with AD 
(see Tran & Smith, 2008). One possible explanation for these seemingly incongruent 
results is that a person’s expectations about alcohol’s effects can motivate drinking 
independently of alcohol’s actual physiological effects, these expectations influence the 
likelihood of drinking to cope which in turn increases the risk of excessive drinking (e.g., 
Abrams & Kushner, 2004). In line with this explanation, men with elevated anxiety 
regarding heterosexual interactions who were told that alcohol enhances social 
performance reported less anxiety after drinking before a heterosexual social interaction 
than men who were told that alcohol impairs social, performance (Keane & Lisman, 
1983). Also, men with SA who held stronger tension reduction expectancies reported less 
anticipatory social anxiety than men who expected less tension reduction from drinking 
(Abrams & Kushner, 2004). Finally, individuals with AD who reported drinking to cope 
had a fivefold increased risk for developing alcohol dependence within 3 years; in 
contrary, people with AD who did not drink to cope showed the same level of risk for 
developing alcohol dependence as people with no anxiety disorders (Menary et al., 2011).  
 
Buckner et al. (2013) proposed a biopsychosocial model for the comorbidity of substance 
use and social anxiety. Figure 4.1 is an adaptation of this model applied to alcohol use.  
The graph illustrates that socially anxious individuals may use alcohol to manage various 
components of social anxiety, for example to cope with unpleasant affective states as well 
as to increase positive affect (Abrams, Kusher, Reinertsen, 2002). Some may use alcohol 
to avoid negative evaluation by their peers (Byers, et al., 2010), some may use it to 
enhance enjoyment during social events (Alden &Wallace, 1995). Finally, the original 
model suggests that some socially anxious individuals may use substances to  help 
decrease physiological arousal, for example, a study on people with social anxiety found 
that cannabidiol (CBD) decreased heart rate and decreased self-reported state of social 
anxiety prior to a speech task (Bergamaschi et al., 2011). However, as previously 
reported (Abrams & Kushner, 2004), the experience of anxiety attenuation following 
alcohol consumption seems to be determined more by individuals’ expectancies, believes 
and motivations rather than the actual physiological response.  
 
*** Insert Figure 4.1 *** 
Caption: Proposed model of the relationship between social anxiety and substance used 
disorders. 
Credit: Adapted from: Buckner, J. D., Heimberg, R. G., Ecker, A. H., & Vinci, C. (2013). 
A biopsychosocial model of social anxiety and substance use. Depression and Anxiety, 
30(3), 276-284. 
 
Research has shown that alcohol expectancies mediate alcohol consumption also in 




























(2019) compared a clinical sample of individuals with severe mental illness (SMI), PSTD 
and comorbid AUD with a sample of patients with similar mental health diagnosis but no 
AUD. They found that compared to people with SMI, PTSD, but no alcohol use disorder, 
those who had co-occurring AUD endorsed more positive expectancies for the effects of 
alcohol on increasing social and sexual behavior, and the experience of power and 
pleasure, but not for the effects on reducing tension and promoting relaxation. The 
authors suggest that AUD in individuals with SMI and PTSD may be related to attempts 
to cope with specific symptom clusters of PTSD, such as feelings of numbness and 
avoidance.  
 
The “alleviation of dysphoria” model has been studied mainly in the context of bipolar 
disorders and schizophrenia (Mueser, Drake, & Wallach, 1998). This model holds that 
people with severe mental illness start drinking alcohol to alleviate the feelings of 
sadness, gloom, inadequacy, discontent, isolation, and boredom. Consistently with this 
model, Laudet, Magura, Vogel & Knight (2004) compared reasons for using substances 
in individuals suffering from bipolar disorder, schizophrenia, and depression. Overall, 
they found that alcohol was the most often cited as “substances used first” (65%). Those 
diagnosed with a bipolar disorder were significantly more likely to cite wanting to fit in 
with peers as the reason to start using alcohol. Contributively, and those with a primary 
diagnosis of schizophrenia showed a significantly lower likelihood of citing emotional or 
mental issues as a reason to start using drugs and alcohol in comparison to the other two 
groups. The role of alcohol as social lubricant for people with severe mental health 
disorders was demonstrated also by Thorton, et al. (2012).  Their study showed that 
reasons for using substances varied according to substance and mental disorder. As 
shown in Table x.1, overall, alcohol was primarily used to cope (79%), and for social 
motives (75%). Interestingly, “To be social/gives me a social life” was cited much more 
frequently by participants with psychosis (21.7%) as opposed to those with depression 
(6.4%), for whom cannabis was the preferred social lubricant. In addition, for the 
psychosis group, to “Take away sad feelings, cheer me up, loneliness” was the most 
frequently cited coping motive (28.3%). In line with Drake and colleagues (Drake, 
Wallach, Alverson, & Mueser, 2002) proposed that the emphasis on biological and 
pharmacological factors in the literature on “dual diagnosis” has diverted attention from 
important psychosocial issues. The authors suggest that factors such as social networks, 
expectancies of drug effects, boredom, dysphoria, unemployment, and poverty “are 
critically important in the presentation, development and course of substance abuse and 
in the process of helping people attain sobriety, stable abstinence and recovery” (p. 100). 
 
Caption: Percentage of Study 5 participants endorsing reasons for tobacco, alcohol and 
cannabis use, collected via free response 
Credit: Taken from: Thornton, L. K., Baker, A. L., Lewin, T. J., Kay-Lambkin, F. J., 
Kavanagh, D., Richmond, R., ... & Johnson, M. P. (2012). Reasons for substance use 
among people with mental disorders. Addictive Behaviors, 37(4), 427-434. 
 
Studies into gender differences suggested that women are more prone to drink to cope 
with symptoms of AD (negative reinforcement) (Norberg et al., 2010) whereas men are 
more likely to drink to enhance their experience (positive reinforcement) (Peltier et al, 
2019). Recent research also demonstrated gender differences in stress-related alcohol use 
might be partly related to the role of ovarian hormones in regulating stress-response (see 
Peltier et al., 2019 for a review on gender differences in stress-related alcohol use).  
 
In conclusion, there is evidence to support the secondary AUD model, however, this 
should be taken with caution as it is associated with at least two limitations: the analyses 
often rely on retrospective self-reported data and findings derive from clinical samples 
can inflate prevalence estimates of self-medication, especially if alcohol-dependent 
individuals are evaluated during acute alcohol withdrawal (Mueser et al., 1998). Despite 
these limitations, this line of research suggests that interventions for co-occurring AUD 
and AD, especially PTSD, should be gender sensitive and consider people’s alcohol 
expectancies and reasons to drink. 
 
(2) The secondary mental health disorders model  
The second hypothesis proposes that AUD can induce MHD via biological, 
psychological, or social processes. For example, Boden & Ferguson’s (2011) metanalysis 
found that the most plausible causal association between AUD and major depression 
(MD) is the one in which AUD increase the risk of MD, rather than vice versa. Churchill 
& Farrell’s (2017) study on 5828 respondents from the Health Survey for England (HSE), 
confirmed the same direction of causality. They also found that higher levels of 
depression were associated with intensity (the volume of alcohol consumed) as opposed 
to frequency of alcohol consumption. There is some evidence that gender might moderate 
order of onset, whereby depression is often an antecedent of drinking problems among 
women but is experienced as a consequence of drinking in men (Schutte et al., 1995; 
Churchill & Farrell, 2017).  
AUD has also been found to precipitate or exacerbate anxiety disorders (AD) and 
psychosis. The section below illustrates some of the biological and mechanisms and 
neurological structures underpinning these causal links.  
Biological and neurological mechanisms  
One explanation of the biological mechanism through which AUD can cause MD is that 
alcohol exposure may generate metabolic changes that also increase the risk of MD.  For 
instance, McEachin, Keller, Saunders, McInnis (2008) found evidence that exposure to 
ethanol leads to reductions in the production of MTHFR (methylenetetrahydrofolate 
reductase), an enzyme related to folate metabolism. Reduced folate levels have, in turn, 
been linked to increased risks of MD, indicating a possible causal link between AUD and 
MD through decreased MTHFR production. Another stream of research focuses on the 
effects that alcohol consumption has on the neurocognitive processes underlying MD. For 
example, trait rumination has been noted to be prevalent in those who suffer with 
depression (Mandell, et al., 2014). Mandell, and colleagues (2014) suggest that it is a risk 
factor towards more intense and harder to treat depressions. Trait rumination is the 
tendency to engage in sustained and repetitive thinking regarding negative thoughts about 
events that have happened in the past. The cognitive processes that have been suggested 
to be important to rumination are automatic attention to negative information, and 
difficulty disengaging from negative information. Therefore, it is hypothesised there is a 
lack of cognitive control mechanisms in place to aid regulation of attention, emotion, and 
emotional processing (Menke, 2019). Mandell, et al., (2014) examined this set of 
mechanisms using 29 adults with a diagnosis of MD. The participants completed an 
FMRI protocol, self-report questionnaires (10 measures on rumination, emotional control, 
and intrusiveness) and qualitative data from clinical interviews. The study found that 
depressed individuals had primarily greater sustained amygdala activity and that related 
areas within the brain such as the hippocampus, dorsal lateral pre frontal cortex, anterior 
insula, medial frontal gyrus and posterior cingulate were activated depending on the type 
of rumination. However, notably the higher amygdala activation was most important as 
this can connote poorer emotional control, higher attention to stimuli that trigger negative 
emotional responses and dysfunctional control in response to internal feelings which may 
be ruminated upon. This may cause more emotional discomfort and distress for the 
individual. In people with chronic AUD, the amygdala is impaired in its function due to 
plastic changes dictated by gene expression such as down regulation of oxyreductases 
(Dager et al., 2015). This is important for energy stores and metabolism in the brain. 
With chronic alcohol use these functions are diminished suggesting reduced neuronal 
energy stores and additionally higher oxidative damage in the brain.  In turn chronic 
alcohol use can lead to reduced neurogenesis which affects plasticity and therefore an 
individual’s response to novel and stressful conditions (Kryger & Wilce, 2010). In 
consideration of this damage through alcohol use a circular issue may occur where 
stimuli become more stressful,  emotional regulation becomes increasingly more difficult, 
and therefore this leads to more reliance of alcohol and its effects of dampening the 
amygdala when intoxicated (Roberto et al., 2012)., Therefore, an already dysfunctional 
hyperactive or hyper-reactive amygdala (as seen in dual diagnosis cases) will be further 
compromised through use of alcohol in attempt to self-medicate rumination, sadness, to 
cope with anxiety or depression symptoms.   
 
In reference to anxiety disorders, there is evidence that chronic alcohol dependence 
results in an overall GABA deficiency that may induce anxiety (Smith & Randall, 2012). 
Withdrawal periods also can induce changes in the brain, which can include excessive 
activity (i.e., hyperexcitability) of certain brain systems (i.e., the limbic system and the 
norepinephrine system) (Kushner et al., 1990), both of which are involved in triggering 
panic attacks (Graeff & Del-Ben, 2008). Repeated withdrawal episodes can lead to neural 
adaptation that makes the drinker more susceptible to anxiety and exacerbates stress-
induced negative affect when alcohol intake stops (Breese et al., 2011). This explains 
why people with alcohol dependence who are recently abstinent report increased feelings 
of anxiety, panic, and phobic-like behaviors in the short term, and symptoms of 
autonomic activity (i.e., sympathetic activation, such as increased heart rate and 
faster/shallower breathing) and persistent anxiety across prolonged withdrawal.  
 
The amygdala has been signified as one of the most supported regions that shows 
hyperactivity or hyperreactivity in people with AUD during fMRI and PET neuroimaging 
(Niciu & |mason, 2014). Withdrawal induced anxiety is part of the functional rebound 
changes from an excess of GABA from chronic use of alcohol and subsequent high 
glutamatergic expression. Considering the Amygdala is primarily GABAergic, the 
disinhibition of downstream brain regions can be problematic for the individual who has 
chronically used or is dependent on alcohol. Downstream brain regions that innervate the 
central amygdala are outlined by Pitkanen, (2000) and include the ventral tegmental area 
(important for reward and production of forebrain dopamine), the locus coeruleus 
(important for stress response) and the medial pre frontal cortex (mPFC). The mPFC has 
been outlined as critical in processing emotionally salient information and facilitates 
behavioural responses to cues. Deregulation of this area has been implicated in addiction 
and in other neuropsychiatric disorders such as schizophrenia, depression, mood, and 
anxiety disorders (Stamatakis et al., 2014).  
 
In reference to psychosis, alcohol can precipitate psychotic symptoms during acute 
intoxication, withdrawal, or chronic use (Archibald, Brunette, Wallin, & Green, 2019). In 
one study in emergency departments, 18.9% of those with a diagnosis of substance-
induced psychosis had alcohol as the primary substance (Canton et al., 2005), patients 
with alcohol-related psychosis have a 5% to 30% risk of developing a chronic 
schizophrenia-like syndrome (Glass, 1989). In chronic alcohol dependent patients, lack of 
thiamine is a common condition. Thiamine deficiency is known to lead to Wernicke-
Korsakoff syndrome, which is characterized by neurological findings on examination and 
a confusional-apathetic state (Peräl et al. 2010). 
 
Psychosocial factors  
From a psychosocial perspective, it can be argued that both anxiety and depression can be 
caused by the social and financial sequalae of alcohol dependence, for example loss of 
employment, financial difficulties, family breakdown, homelessness, ill health and 
isolation (e.g. Foster, Powell, Marshall and Peters, 1999). However, studies that have 
accounted for the possible influence of a range of life circumstances in the causal link 
between AUD and major depression have found that these links persist even after 
controlling for social and environmental factors (Hasin & Grant, 2002; Paljarvi et al., 
2009; Sihvola, et al., 2008). Whereas there is support evidence for life stressors to 
generate anxiety disorders. There are least two ways that can explain this causal link: 
first, the consistent presence of life stressors can intensify anxiety symptoms among 
already vulnerable individuals. Second, as explained in the earlier section, alcohol use in 
the presence of stress stimuli may interfere with extinction-based learning necessary for 
normal adaptation to stressors. Thus, AUD can lead to anxiety through a combination of 
greater levels of life stress coupled with poor coping skills (Smith and Randall, 2012). 
(3) The common risk factors model  
Recent research provides increasing support for the perspective that AUD and co-
occurring MHD share underlying, mutually exacerbating, neurological and psychosocial 
processes.  
 
Common biological risk factors have received considerable support in the context of 
Borderline Personality Disorders (BPD) and Antisocial Personality Disorders (ASPD).  
BPD and ASPD tend to relate similarly to AUD in terms of impulsivity, negative affect, 
and externalizing correlates; this commonality has been linked to the sharing of general 
personality traits, particularly antagonism and impulsivity (disinhibition) (Helle et al., 
2019). For example, using a multivariate behavioral genetic twin design, Slutske et al., 
(2002) found that the genetic variance associated with impulsivity, novelty seeking, and 
aggression, accounted for 40% of   the genetic variance in alcohol dependence. These 
findings support the notion that the overlap of impulsivity and AUD originates from 
shared genetic mechanisms. Bornovalova, et al. (2013) have demonstrated the same for 
AUD and BPD. This common genetic mechanism appears to generate externalizing 
behavior and psychopathology generally, including AUD, other substance use disorder, 
conduct disorder, and antisocial behavior (Helle et al., 2019).  
 
Genetic research has also found evidence of increased risks of both AUD and major 
depression (MD) among individuals with specific genotypes (Boden & Fergusson, 2011). 
For instance, studies by Wang et al. (2004) and Luo et al. (2005) found that variants of 
the muscarinic acetylcholine receptor M2 (CRHM2) gene are related to increased risks of 
both disorders. Similarly, several polymorphisms (genetic variations) of the brain-derived 
neurotrophic factor (BDNF) protein correlate with co-occurring schizophrenia and 
alcohol dependence but not with alcohol dependence alone, suggesting that these 
polymorphisms may contribute to a specific vulnerability to these co-occurring disorders 
(Hartz et al., 2017). 
 
From a psychosocial perspective, trauma is a risk factor for both MHD and SUD, 
including AUD. Rates of trauma exposure in psychiatric inpatients range from 53% to 
100% (McFarlane, Bookless, & Air, 2001), while about 90% of individuals with SMI 
(severe mental illness) report having experienced at least one traumatic event, most of 
whom have been multiply traumatised (Goodman et al., 1997; Mueser et al., 1998). As 
illustrated in the epidemiological section, rates of AUD among people with PTSD is high. 
There is growing evidence of the shared neurobiological mechanisms that link AUD and 
PTSD. Neuroimaging studies have found that dysregulation in the hippocampus and the 
amygdala are implicated in both PTSD and AUD (Logue, et al., 2018; Norman, et al., 
2012). The amygdala has been shown to be reduced in size within children who endured 
early life stress and/or trauma such as physical abuse, low socioeconomic status, and 
neglect (Hanson et al., 2015). Additionally, these structural changes have been identified 
in individuals who have survived a life-threatening illness or worked in critical care with 
life threatening or terminal illness and whom display PTSD symptoms from their ordeal 
(Matsuoka, et al., 2003; Stevens, et al., 2017). Hyperactive and or hyper-reactive activity 
in the amygdala (Gilpin & Weiner, 2017) have been shown in many studies concerning 
PTSD in combat veterans and inter-partner violence studies (Poirier, et al., 2013). 
Furthermore, women who have undergone intimate partner violence and who suffer with 
PTSD showed hyperactivation in the amygdala when exposed to fearful faces (Fonzo, et 
al., 2010). Like individuals diagnosed with PTSD, people who are diagnosed with AUD 
exhibit functional and structural changes in relation to the amygdala. Lower Amygdala 
volume has been reported in individuals with AUD (Dager, et al., 2015) and has been 
associated with higher alcohol drinking up to 6 months after imaging. However, to date 
there is a paucity of neuro imaging studies that investigate individuals with comorbid 
PTSD and AUD. One study by Nikolova, et al., (2016) used blood-oxygen-level-
dependent functional magnetic resonance imaging to explore the relationship between 
alcohol use and levels of stress in a sample of 759 undergraduate students and 
demonstrated that problem drinking was highest in the context of stress. The study also 
showed that participants with higher levels of problem drinking displayed either high 
threat-related reactivity of the amygdala combined with low reward-related activity of the 
ventral striatum (VS) or low threat-related reactivity of the amygdala combined with high 
reward-related activity of the VS. These results suggest that the relationship between 
neural activity and stress-related AUD may not be simply related to activity in one brain 
region, but rather may depend on convergent or divergent (re)activity in multiple brain 
regions. Semple, et al., (2000) used positron emission tomography to compare regional 
blood flow (rCBF) in patients with PTSD, alcohol and cocaine misuse at rest and during 
an auditory continuous performance task (ACPT). They found higher rCBF in the right 
amygdala and left parahippocampal gyrus, and lower blood flow in the frontal cortical 
regions for individuals with comorbid PTSD and alcohol or cocaine misuse in 
comparison to healthy controls, however one limitation of this study was that there were 
no PTSD-only and AUD-only comparison groups. A recent line of research has proposed 
that medial prefrontal cortex subregion (mPFC) projections to extended amygdala nuclei 
control fear and drug-seeking behaviours, and that dysregulation of these top-down PFC 
projections may lead to the abnormal fear conditioning that characterises PTSD and the 
compulsive drug-seeking behaviour in AUD (Peters et al. 2009). It has been suggested 
that the medial prefrontal cortex (mPFC) is impaired over time with excessive drinking 
and these impairments are similar to those seen in research regarding repeated stress. 
Accordingly, Holmes et al., (2012) examined the effects of excessive alcohol exposure on 
mice and found that there was a diminished capacity of the mPFC to mediate fear 
extinction. Below is a description of the fear/addiction circuitry to illustrate the 
connection. The mPFC is included in the pre-frontal cortex (PFC) and therefore is a part 
of this network. It has been suggested to be integral in working with the amygdala which 
is influenced by the Hypothalamus Pituitary Axis (HPA) Axis and other fear circuitry. 
This circuitry is important in dampening emotional responses to fear, and its 
dysregulation plays a part in self-medication using alcohol to cope with internal and 
external stressors that are present for individuals who suffer with PTSD, see Figure x  
(Suh & Ressler, 2018). 
 
*** Insert Figure 4.2 *** 
Caption: Interactions between the fear/addiction neural circuitry and the hypothalamic 
pituitary adrenal (HPA) axis. 
Credit: Suh, J., & Ressler, K. J. (2018). Common Biological Mechanisms of Alcohol Use 
Disorder and Post-Traumatic Stress Disorder. Alcohol research: current reviews, 39(2), 
131–145. 
 
The above model is taken from Suh & Ressler (2018) and it shows the fear and addiction 
circuitry that is discussed in their review of common biological mechanisms of AUD and 
PTSD. The PFC and amygdala are mutually connected and the amygdala projects to the 
Nucleus Acumens via glutamatergic innervations. All areas illustrated above receive 
projections from dopamine neurons in the ventral tegmental area (VTA). The major 
components of the HPA include the paraventricular nucleus (PN) of the hypothalamus 
and the pituitary and adrenal glands. Corticotropin releasing hormone (CRH) from the 
PN stimulates release of adrenocorticotropic hormone (ACTH) from the anterior pituitary 
into the venal system. ATCH induces glucocorticoid release from the adrenal glands. 
Glucocorticoids mediate negative feedback regarding the HPA axis and directs it to 
reduce the stress response. Furthermore, Glucocorticoids affect the fear / addiction 
circuitry via their own receptors which can trigger physiological, cellular and molecular 
changes which in turn causes genetic alterations (epigenetic changes).  
 
In summary, stress is a likely common neurobiological link between the processes of 
substance use disorders, including AUD, and anxiety disorders. Stress responses are 
mediated through the HPA axis, which in turn can influence brain circuits that control 
motivation. Higher levels of stress have been shown to reduce activity in the prefrontal 
cortex and increase responsivity in the striatum, which leads to decreased behavioral 
control, increased impulsivity, and increased compulsive behaviors. Early life stress, 
isolation, trauma and chronic stress can also cause long-term alterations in the HPA axis, 
which affects limbic brain circuits that are involved in motivation, learning, and 
adaptation, which4are impaired in individuals with AUD and MHD. 
 
Scientists are also beginning to understand the ways that genetic and environmental 
factors interact at the molecular level. Chronic stress caused by social factors such as 
isolation,  homelessness, financial difficulties, trauma, or drug and alcohol exposure can 
induce stable changes that affect how genetic information is read and acted on by cells in 
the body (see Figure  4.3 and Wong, Mill & Fernandes, 2011, for a review on epigenetics 
in addiction). These alterations contribute to the development of MHD and addiction.  
However, there is also evidence that some of these changes can be reversed with 
interventions or environmental alteration (Guintivano & Kaminsky, 2016). 
 
*** Insert Figure 4.3 *** 
Caption: The proposed relationship between inherited predispositions, environmental 
factors, exposure to addictive substances and vulnerability to addictive disorders. When 
exposed to adverse environmental stimuli, individuals carrying susceptibility genes or 
epialleles predisposing to addictive behaviours may have an increased risk of developing 
addiction. Acute substance use may produce enduring alterations in gene expression via 
epigenetic changes that influence susceptibility to addictive disorders. Enhanced 
vulnerability to substances of abuse will then feed back into increased risk of future drug 
use (as shown by the dashed arrow) that bring about further modifications to the 
epigenome and gene expression 
Credit: taken from: Wong, C.C.Y., Mill, J., Fernandes, C. (2011) Drugs and addiction: an 
introduction to epigenetics. Addiction, 106 (3), 480-489. 
 
In conclusion, there is evidence to support all three main theoretical models of co-
occurring AUD and MHD. However, it is becoming clear that the interaction between the 
two conditions is complex and, in many cases, bidirectional, with one reinforcing the 
other in a cyclic fashion (e.g. Suh & Ressler, 2018). Although it is important to try and 
disentangle the interaction between AUD and MHD, ultimately, regardless of the 
etiological model, these disorders are strongly associated. Thus, treatment must address 
both the MHD symptoms and AUD in an integrated fashion.  
 
Research into the common underlying mechanisms indicates that interventions should aid 
individuals with such comorbidity develop skills to cope with the consequences of trauma 
and with stress. The evidence presented in this chapter also suggests that women are 
more likely to use alcohol to deal with symptoms of anxiety and stress in comparison to 
men, they are also more likely to have been victim of sexual abuse, they tend to display 
more severe psychiatric symptoms and more severe AUD related complications (see 
Gearon et al., 2011; Peltier, 2019). As a result, women have a greater number of service 
needs, especially for treatment related to family and trauma issues (Grella, 2003). 
Therefore, it is recommended that treatment interventions should be gender sensitive.  
 
The strong connection between mental and alcohol use disorders indicates that 
transdiagnostic therapeutic protocols might be the way forward. The interplay between 
the psychological and biological factors imply that therapeutic approaches may require a 
combination of pharmacological and psychosocial interventions. Finally, the complex 
and multiple needs of individuals with "dual diagnosis" can only be met if treatment and 
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